These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7332156)

  • 1. EA-rosette test in cervical cell suspensions.
    Noltenius H; Bergmann R
    Anal Quant Cytol; 1981 Dec; 3(4):281-8. PubMed ID: 7332156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the EA-rosette test in the early detection of cervical cancer.
    Wagner D; Noltenius HW
    Acta Cytol; 1983; 27(4):403-7. PubMed ID: 6576540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Fc receptor-bearing cells are detected with the Ripley assay?
    Andersson TR; Svennevig JL
    Clin Exp Immunol; 1981 Apr; 44(1):167-72. PubMed ID: 7261473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of guinea pig T lymphocytes after E rosette formation -expression of Fc and complement receptors-(author's transl)].
    Yasumizu R
    Hokkaido Igaku Zasshi; 1981 May; 56(3):347-54. PubMed ID: 6976298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The electrophoresis mobility (em) test in cervical-intra-epithelial neoplasia (c.i.n.) (author's transl)].
    Bögelspacher HR; Tautz C; Geppert M
    Geburtshilfe Frauenheilkd; 1980 Jun; 40(6):545-9. PubMed ID: 7409420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic marker features in dysplastic cells from the uterine cervix.
    Wied GL; Bartels PH; Dytch HE; Pishotta FT; Yamauchi K; Bibbo M
    Acta Cytol; 1982; 26(4):475-83. PubMed ID: 6957100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin cytochemistry in the exfoliative cytology of uterine cervix.
    Remani P; Pillai KR; Haseenabeevi VM; Ankathil R; Bhattathiri VN; Nair MK; Vijayakumar T
    Neoplasma; 1994; 41(1):39-42. PubMed ID: 8202194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of cervical dysplasias].
    Pérez Dettoma J; Santamaría M; Jurado M; Cabezón C; Domínquez J; de la Fuente F; López García G
    Rev Med Univ Navarra; 1980 Dec; 24(4):26-9. PubMed ID: 7336009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cervical conization in dysplasia and carcinoma in situ. Role of concomitant uterine curettage].
    Kazadi Buanga J; Acosta Vazquez MJ
    Rev Fr Gynecol Obstet; 1994 Dec; 89(12):602-5. PubMed ID: 7846467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytology and colposcopy in the diagnosis and management of outpatients with cervical intraepithelial neoplasia.
    Allahverdian V; Valaitis J; Kalis O; Pearlman S
    J Reprod Med; 1980 Jan; 24(1):1-4. PubMed ID: 7359496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of single-cell classification schemes for computer classification of cervical cells.
    Poulsen RS; Oliver LH; Toussaint GT; Louis C
    Anal Quant Cytol; 1981 Sep; 3(3):207-15. PubMed ID: 7294540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EA rosettes using IgG monoclonal antibody-coated erythrocytes: degree of rosette formation correlates with the amount of antibody on the erythrocytes.
    Dennis JW; Kerbel RS; Roder JC
    Scand J Immunol; 1981 Nov; 14(5):537-44. PubMed ID: 7336173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of EA-rosette formation blockade by antisera against cell surface antigens].
    Bogdanova IM; Malaĭtsev VV
    Biull Eksp Biol Med; 1980 Oct; 90(10):453-6. PubMed ID: 7426708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the determination of IgG-Fc receptor bearing cells and T gamma-cells of human lymphocytes--with a special reference to the comparison of EA rosette method and double rosette methods (author's transl)].
    Iho S; Kojima C; Nishimoto S; Furukawa H; Takahashi T; Hoshino T
    Rinsho Byori; 1980; 28(6):591-6. PubMed ID: 6967979
    [No Abstract]   [Full Text] [Related]  

  • 19. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.
    Berner A; Høeg K; Oppedal BR
    Diagn Gynecol Obstet; 1980; 2(2):99-101. PubMed ID: 7439010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.